Jump to content

Akshay Nair: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
BattyBot (talk | contribs)
m Removed/fixed incorrect author parameter(s), performed general fixes
added reference
Line 10: Line 10:
Dr. Nair was one of the first clinicians to report and study the association between the invasive fungal infection [[Mucormycosis]] and [[COVID-19]] which was seen after the second wave of the [[COVID-19 pandemic in India]].<ref>{{Cite web |date=2021-05-13 |title='I told her either it’s your eyes or your life': Doctors share the 'black fungus' nightmare facing India's Covid-19 patients |url=https://www.asiaone.com/world/i-told-her-either-it-s-your-eyes-or-your-life-doctors-share-black-fungus-nightmare-facing |access-date=2022-12-13 |website=AsiaOne |language=en}}</ref><ref>{{Cite news |date=2021-05-09 |title=Mucormycosis: The 'black fungus' maiming Covid patients in India |language=en-GB |work=BBC News |url=https://www.bbc.com/news/world-asia-india-57027829 |access-date=2022-12-13}}</ref><ref name=":0">{{Cite news |last=Delhi |first=Amrit Dhillon |title=Covid in India: Thousands need eyes removed over ‘black fungus’ |language=en |url=https://www.thetimes.co.uk/article/covid-in-india-thousands-need-eyes-removed-over-black-fungus-9623kcrd6 |access-date=2022-12-13 |issn=0140-0460}}</ref><ref>{{Cite journal |last=Nair |first=Akshay Gopinathan |last2=Adulkar |first2=Namrata G. |last3=D’Cunha |first3=Lynn |last4=Rao |first4=Priyanka R. |last5=Bradoo |first5=Renuka A. |last6=Bapaye |first6=Maneesh M. |last7=Kothari |first7=Abhishek |last8=Dave |first8=Tarjani V. |last9=Shinde |first9=Chhaya A. |date=2021-11-02 |title=Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients |url=https://www.tandfonline.com/doi/full/10.1080/01676830.2021.1960382 |journal=Orbit |language=en |volume=40 |issue=6 |pages=499–504 |doi=10.1080/01676830.2021.1960382 |issn=0167-6830}}</ref><ref name=":1">{{Cite journal |last=Nair |first=Akshay Gopinathan |last2=Dave |first2=Tarjani Vivek |date=2022-05-04 |title=Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review |url=https://www.tandfonline.com/doi/full/10.1080/01676830.2021.1990351 |journal=Orbit |language=en |volume=41 |issue=3 |pages=275–286 |doi=10.1080/01676830.2021.1990351 |issn=0167-6830}}</ref><ref>{{Cite journal |last=Dave |first=Tarjani Vivek |last2=Gopinathan Nair |first2=Akshay |last3=Hegde |first3=Raghuraj |last4=Vithalani |first4=Nidhi |last5=Desai |first5=Savari |last6=Adulkar |first6=Namrata |last7=Kamal |first7=Saurabh |last8=Mittal |first8=Raman |last9=Bradoo |first9=Renuka A. |date=September–October 2021 |title=Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study |url=https://journals.lww.com/op-rs/Fulltext/2021/09000/Clinical_Presentations,_Management_and_Outcomes_of.17.aspx |journal=Ophthalmic Plastic & Reconstructive Surgery |language=en-US |volume=37 |issue=5 |pages=488–495 |doi=10.1097/IOP.0000000000002030 |issn=0740-9303}}</ref> Notably, in 2021 Nair and Dave proposed a novel protocol for case selection of patients suitable for orbital injection of the antifungal drug, Amphotericin-B which has helped improve outcomes in rhino-orbital mucormycosis, a disease traditionally known to have high mortality rates.<ref name=":1" /> In this regard, he has been interviewed as an expert extensively by [[The Times]], [[BBC News]], [[Barkha Dutt]], Qatar-based news channel [[Al Jazeera]], the French daily [[Le Figaro]] and [[The Washington Post]].<ref name=":0" /><ref>{{Citation |title=BBC World Interview - Dr. Akshay Nair, Oculoplastic Surgeon from Mumbai, India. |url=https://www.youtube.com/watch?v=mil0gyhIhOE |language=en |access-date=2022-12-13}}</ref><ref>{{Citation |title=Al Jazeera English News Interview - Dr. Akshay Nair, Oculoplastic Surgeon on Mucormycosis in India. |url=https://www.youtube.com/watch?v=C4VLr5nwmbk |language=en |access-date=2022-12-13}}</ref><ref>{{Citation |title=Dr. Akshay Nair, Oculoplastic Surgeon on The News Hour, Times Now on Mucormycosis / Black Fungus. |url=https://www.youtube.com/watch?v=dg1rwONElEs |language=en |access-date=2022-12-13}}</ref><ref>{{Cite news |date=2021-08-10 |title=Covid-19: Fears over sharp rise in diabetes in India |language=en-GB |work=BBC News |url=https://www.bbc.com/news/world-asia-india-58066767 |access-date=2022-12-13}}</ref><ref>{{Cite web |last=Sorongan |first=Tommy Patrio |title=Mengenal Jamur Hitam, Wabah Baru Serang Ribuan Orang di India |url=https://www.cnbcindonesia.com/lifestyle/20210525083020-33-248097/mengenal-jamur-hitam-wabah-baru-serang-ribuan-orang-di-india |access-date=2022-12-13 |website=CNBC Indonesia |language=id-ID}}</ref><ref>{{Citation |title=Black Fungus: Survive COVID, Then Lose an Eye, or your Life {{!}} Misuse of Steroids {{!}} India COVID Wave |url=https://www.youtube.com/watch?v=75L-gxlHq7U |language=en |access-date=2022-12-13}}</ref> As of 2022, Dr. Akshay Nair has published over 120 scientific papers in peer-reviewed journals and features in the top 2% of the most-cited researchers globally in 2021 across all specialities (published by [[Elsevier]]).<ref>{{Cite web |title=Akshay Gopinathan Nair |url=https://scholar.google.co.in/citations?user=CkEPBJIAAAAJ&hl=en |access-date=2022-12-13 |website=scholar.google.co.in}}</ref><ref>{{Cite journal |last=Ioannidis |first=John P. A. |date=2022-11-03 |title=September 2022 data-update for "Updated science-wide author databases of standardized citation indicators" |url=https://elsevier.digitalcommonsdata.com/datasets/btchxktzyw |language=en |volume=5 |doi=10.17632/btchxktzyw.5}}</ref><ref>{{Cite web |date=2022-10-24 |title=Top 2% Most Influential Scientists (Single Year) in 2023 Stanford University List: Analysis of Indian Researchers |url=https://insights2techinfo.com/top-2-most-influential-scientists-single-year-in-2023-stanford-university-list-analysis-of-indian-researchers/ |access-date=2022-12-13 |website=Insights2Techinfo |language=en-US}}</ref>
Dr. Nair was one of the first clinicians to report and study the association between the invasive fungal infection [[Mucormycosis]] and [[COVID-19]] which was seen after the second wave of the [[COVID-19 pandemic in India]].<ref>{{Cite web |date=2021-05-13 |title='I told her either it’s your eyes or your life': Doctors share the 'black fungus' nightmare facing India's Covid-19 patients |url=https://www.asiaone.com/world/i-told-her-either-it-s-your-eyes-or-your-life-doctors-share-black-fungus-nightmare-facing |access-date=2022-12-13 |website=AsiaOne |language=en}}</ref><ref>{{Cite news |date=2021-05-09 |title=Mucormycosis: The 'black fungus' maiming Covid patients in India |language=en-GB |work=BBC News |url=https://www.bbc.com/news/world-asia-india-57027829 |access-date=2022-12-13}}</ref><ref name=":0">{{Cite news |last=Delhi |first=Amrit Dhillon |title=Covid in India: Thousands need eyes removed over ‘black fungus’ |language=en |url=https://www.thetimes.co.uk/article/covid-in-india-thousands-need-eyes-removed-over-black-fungus-9623kcrd6 |access-date=2022-12-13 |issn=0140-0460}}</ref><ref>{{Cite journal |last=Nair |first=Akshay Gopinathan |last2=Adulkar |first2=Namrata G. |last3=D’Cunha |first3=Lynn |last4=Rao |first4=Priyanka R. |last5=Bradoo |first5=Renuka A. |last6=Bapaye |first6=Maneesh M. |last7=Kothari |first7=Abhishek |last8=Dave |first8=Tarjani V. |last9=Shinde |first9=Chhaya A. |date=2021-11-02 |title=Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients |url=https://www.tandfonline.com/doi/full/10.1080/01676830.2021.1960382 |journal=Orbit |language=en |volume=40 |issue=6 |pages=499–504 |doi=10.1080/01676830.2021.1960382 |issn=0167-6830}}</ref><ref name=":1">{{Cite journal |last=Nair |first=Akshay Gopinathan |last2=Dave |first2=Tarjani Vivek |date=2022-05-04 |title=Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review |url=https://www.tandfonline.com/doi/full/10.1080/01676830.2021.1990351 |journal=Orbit |language=en |volume=41 |issue=3 |pages=275–286 |doi=10.1080/01676830.2021.1990351 |issn=0167-6830}}</ref><ref>{{Cite journal |last=Dave |first=Tarjani Vivek |last2=Gopinathan Nair |first2=Akshay |last3=Hegde |first3=Raghuraj |last4=Vithalani |first4=Nidhi |last5=Desai |first5=Savari |last6=Adulkar |first6=Namrata |last7=Kamal |first7=Saurabh |last8=Mittal |first8=Raman |last9=Bradoo |first9=Renuka A. |date=September–October 2021 |title=Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study |url=https://journals.lww.com/op-rs/Fulltext/2021/09000/Clinical_Presentations,_Management_and_Outcomes_of.17.aspx |journal=Ophthalmic Plastic & Reconstructive Surgery |language=en-US |volume=37 |issue=5 |pages=488–495 |doi=10.1097/IOP.0000000000002030 |issn=0740-9303}}</ref> Notably, in 2021 Nair and Dave proposed a novel protocol for case selection of patients suitable for orbital injection of the antifungal drug, Amphotericin-B which has helped improve outcomes in rhino-orbital mucormycosis, a disease traditionally known to have high mortality rates.<ref name=":1" /> In this regard, he has been interviewed as an expert extensively by [[The Times]], [[BBC News]], [[Barkha Dutt]], Qatar-based news channel [[Al Jazeera]], the French daily [[Le Figaro]] and [[The Washington Post]].<ref name=":0" /><ref>{{Citation |title=BBC World Interview - Dr. Akshay Nair, Oculoplastic Surgeon from Mumbai, India. |url=https://www.youtube.com/watch?v=mil0gyhIhOE |language=en |access-date=2022-12-13}}</ref><ref>{{Citation |title=Al Jazeera English News Interview - Dr. Akshay Nair, Oculoplastic Surgeon on Mucormycosis in India. |url=https://www.youtube.com/watch?v=C4VLr5nwmbk |language=en |access-date=2022-12-13}}</ref><ref>{{Citation |title=Dr. Akshay Nair, Oculoplastic Surgeon on The News Hour, Times Now on Mucormycosis / Black Fungus. |url=https://www.youtube.com/watch?v=dg1rwONElEs |language=en |access-date=2022-12-13}}</ref><ref>{{Cite news |date=2021-08-10 |title=Covid-19: Fears over sharp rise in diabetes in India |language=en-GB |work=BBC News |url=https://www.bbc.com/news/world-asia-india-58066767 |access-date=2022-12-13}}</ref><ref>{{Cite web |last=Sorongan |first=Tommy Patrio |title=Mengenal Jamur Hitam, Wabah Baru Serang Ribuan Orang di India |url=https://www.cnbcindonesia.com/lifestyle/20210525083020-33-248097/mengenal-jamur-hitam-wabah-baru-serang-ribuan-orang-di-india |access-date=2022-12-13 |website=CNBC Indonesia |language=id-ID}}</ref><ref>{{Citation |title=Black Fungus: Survive COVID, Then Lose an Eye, or your Life {{!}} Misuse of Steroids {{!}} India COVID Wave |url=https://www.youtube.com/watch?v=75L-gxlHq7U |language=en |access-date=2022-12-13}}</ref> As of 2022, Dr. Akshay Nair has published over 120 scientific papers in peer-reviewed journals and features in the top 2% of the most-cited researchers globally in 2021 across all specialities (published by [[Elsevier]]).<ref>{{Cite web |title=Akshay Gopinathan Nair |url=https://scholar.google.co.in/citations?user=CkEPBJIAAAAJ&hl=en |access-date=2022-12-13 |website=scholar.google.co.in}}</ref><ref>{{Cite journal |last=Ioannidis |first=John P. A. |date=2022-11-03 |title=September 2022 data-update for "Updated science-wide author databases of standardized citation indicators" |url=https://elsevier.digitalcommonsdata.com/datasets/btchxktzyw |language=en |volume=5 |doi=10.17632/btchxktzyw.5}}</ref><ref>{{Cite web |date=2022-10-24 |title=Top 2% Most Influential Scientists (Single Year) in 2023 Stanford University List: Analysis of Indian Researchers |url=https://insights2techinfo.com/top-2-most-influential-scientists-single-year-in-2023-stanford-university-list-analysis-of-indian-researchers/ |access-date=2022-12-13 |website=Insights2Techinfo |language=en-US}}</ref>


Dr. Nair also serves as a consultant for HelpMeSee in developing in a surgical simulator.<ref>{{Cite web |last=PR |first=ANI |date=2022-11-23 |title=Value of simulation-based training for cataract surgery highlighted in new articles in Indian Journal of Ophthalmology |url=https://theprint.in/ani-press-releases/value-of-simulation-based-training-for-cataract-surgery-highlighted-in-new-articles-in-indian-journal-of-ophthalmology/1231090/ |access-date=2022-12-13 |website=ThePrint |language=en-US}}</ref> He is also an elected officer in the executive committee of the Asia Pacific Society of Ophthalmic Plastic and Reconstructive Surgery.<ref>{{Cite web |title=Asia Pacific Society Of Ophthalmic Plastic & Reconstructive Surgery {{!}} Officers |url=https://apsoprs.org/officers |access-date=2022-12-13 |website=apsoprs.org}}</ref>
Dr. Nair also serves as a consultant for HelpMeSee in developing in a surgical simulator.<ref>{{Cite web |last=PR |first=ANI |date=2022-11-23 |title=Value of simulation-based training for cataract surgery highlighted in new articles in Indian Journal of Ophthalmology |url=https://theprint.in/ani-press-releases/value-of-simulation-based-training-for-cataract-surgery-highlighted-in-new-articles-in-indian-journal-of-ophthalmology/1231090/ |access-date=2022-12-13 |website=ThePrint |language=en-US}}</ref> He is also an elected officer in the executive committee of the Asia Pacific Society of Ophthalmic Plastic and Reconstructive Surgery.<ref>{{Cite journal |last=Nair |first=Akshay Gopinathan |last2=Narayanan |first2=Natasha |last3=Ali |first3=Mohammad Javed |date=2020-12-31 |title=A Survey on the Impact of COVID-19 on Lacrimal Surgery: The Asia-Pacific Perspective |url=https://www.tandfonline.com/doi/abs/10.2147/OPTH.S279728 |journal=Clinical Ophthalmology |volume=14 |pages=3789–3799 |doi=10.2147/OPTH.S279728 |issn=1177-5467 |pmc=PMC7649246 |pmid=33177805}}</ref><ref>{{Cite web |title=Asia Pacific Society Of Ophthalmic Plastic & Reconstructive Surgery {{!}} Officers |url=https://apsoprs.org/officers |access-date=2022-12-13 |website=apsoprs.org}}</ref>


== Awards / Honors ==
== Awards / Honors ==

Revision as of 05:41, 21 February 2023

Akshay Nair is an Indian ophthalmologist based in Mumbai, India. He specializes in oculoplastics and ocular oncology. Currently, Dr. Nair is the Director of Ophthalmic plastic surgery and ocular oncology services at the Mumbai units of Dr. Agarwal's Eye Hospital: Advanced Eye Hospital and Institute and Aditya Jyot Eye Hospital.

Akshay Nair
Born
Mumbai, India
CitizenshipIndian
EducationDiplomate of National Board
Alma materSankara Nethralaya, L V Prasad Eye Institute, New York Eye and Ear Infirmary of Mount Sinai
OccupationOphthalmologist
RelativesIndumati Gopinathan (mother)
Medical career
ResearchOphthalmology

Medical career

Born in 1984, Dr. Nair trained in ophthalmology at Sankara Nethralaya in Chennai, India. He subsequently completed a fellowship in oculoplastics and ocular oncology at L. V. Prasad Eye Institute under Santosh Honavar among others. He also completed a fellowship supported by the International Council of Ophthalmology at the New York Eye and Ear Infirmary of Mount Sinai in New York, USA.[1]

Dr. Nair was one of the first clinicians to report and study the association between the invasive fungal infection Mucormycosis and COVID-19 which was seen after the second wave of the COVID-19 pandemic in India.[2][3][4][5][6][7] Notably, in 2021 Nair and Dave proposed a novel protocol for case selection of patients suitable for orbital injection of the antifungal drug, Amphotericin-B which has helped improve outcomes in rhino-orbital mucormycosis, a disease traditionally known to have high mortality rates.[6] In this regard, he has been interviewed as an expert extensively by The Times, BBC News, Barkha Dutt, Qatar-based news channel Al Jazeera, the French daily Le Figaro and The Washington Post.[4][8][9][10][11][12][13] As of 2022, Dr. Akshay Nair has published over 120 scientific papers in peer-reviewed journals and features in the top 2% of the most-cited researchers globally in 2021 across all specialities (published by Elsevier).[14][15][16]

Dr. Nair also serves as a consultant for HelpMeSee in developing in a surgical simulator.[17] He is also an elected officer in the executive committee of the Asia Pacific Society of Ophthalmic Plastic and Reconstructive Surgery.[18][19]

Awards / Honors

  • 2011: All India Ophthalmological Society: S D Athawale Award for Best Paper in Neuro-Ophthalmology
  • 2016: Raman Mittal Award for Best Original Free Paper in any field of Ophthalmic Plastic, Reconstructive and Aesthetic Surgery by the Oculoplastics Association of India.[20]
  • 2018: Gangadhara Sundar Award for Best Original Free Paper presented by a Young Ophthalmologist - awarded by the Oculoplastics Association of India.[21]
  • 2019: Achievement Award by the American Academy of Ophthalmology[22]
  • 2019: Achievement Award by the Asia Pacific Academy of Ophthalmology[23]
  • 2021: All India Ophthalmological Society: Best Paper in Ophthalmic Pathology/Oncology

Selected books/chapters

  • Evisceration and Enucleation[24]
  • The Role of Photography in Oculofacial Aesthetics[25]
  • Retinal and Choroidal Imaging in Neurological disease[26]
  • Imaging of Retinal and Choroidal Metastases[27]
  • Life-Threatening Infections: Emergencies of the Orbit and Adnexa[28]
  • Sebaceous Gland Carcinoma[29]
  • Periocular and Adnexal Injuries Due to Animal Bites[30]

References

  1. ^ "ICO Fellows at the New York Eye and Ear Infirmary" (PDF). ICO Fellows - NYEE. 13 December 2022.{{cite web}}: CS1 maint: url-status (link)
  2. ^ "'I told her either it's your eyes or your life': Doctors share the 'black fungus' nightmare facing India's Covid-19 patients". AsiaOne. 2021-05-13. Retrieved 2022-12-13.
  3. ^ "Mucormycosis: The 'black fungus' maiming Covid patients in India". BBC News. 2021-05-09. Retrieved 2022-12-13.
  4. ^ a b Delhi, Amrit Dhillon. "Covid in India: Thousands need eyes removed over 'black fungus'". ISSN 0140-0460. Retrieved 2022-12-13.
  5. ^ Nair, Akshay Gopinathan; Adulkar, Namrata G.; D’Cunha, Lynn; Rao, Priyanka R.; Bradoo, Renuka A.; Bapaye, Maneesh M.; Kothari, Abhishek; Dave, Tarjani V.; Shinde, Chhaya A. (2021-11-02). "Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients". Orbit. 40 (6): 499–504. doi:10.1080/01676830.2021.1960382. ISSN 0167-6830.
  6. ^ a b Nair, Akshay Gopinathan; Dave, Tarjani Vivek (2022-05-04). "Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review". Orbit. 41 (3): 275–286. doi:10.1080/01676830.2021.1990351. ISSN 0167-6830.
  7. ^ Dave, Tarjani Vivek; Gopinathan Nair, Akshay; Hegde, Raghuraj; Vithalani, Nidhi; Desai, Savari; Adulkar, Namrata; Kamal, Saurabh; Mittal, Raman; Bradoo, Renuka A. (September–October 2021). "Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study". Ophthalmic Plastic & Reconstructive Surgery. 37 (5): 488–495. doi:10.1097/IOP.0000000000002030. ISSN 0740-9303.
  8. ^ BBC World Interview - Dr. Akshay Nair, Oculoplastic Surgeon from Mumbai, India., retrieved 2022-12-13
  9. ^ Al Jazeera English News Interview - Dr. Akshay Nair, Oculoplastic Surgeon on Mucormycosis in India., retrieved 2022-12-13
  10. ^ Dr. Akshay Nair, Oculoplastic Surgeon on The News Hour, Times Now on Mucormycosis / Black Fungus., retrieved 2022-12-13
  11. ^ "Covid-19: Fears over sharp rise in diabetes in India". BBC News. 2021-08-10. Retrieved 2022-12-13.
  12. ^ Sorongan, Tommy Patrio. "Mengenal Jamur Hitam, Wabah Baru Serang Ribuan Orang di India". CNBC Indonesia (in Indonesian). Retrieved 2022-12-13.
  13. ^ Black Fungus: Survive COVID, Then Lose an Eye, or your Life | Misuse of Steroids | India COVID Wave, retrieved 2022-12-13
  14. ^ "Akshay Gopinathan Nair". scholar.google.co.in. Retrieved 2022-12-13.
  15. ^ Ioannidis, John P. A. (2022-11-03). "September 2022 data-update for "Updated science-wide author databases of standardized citation indicators"". 5. doi:10.17632/btchxktzyw.5. {{cite journal}}: Cite journal requires |journal= (help)
  16. ^ "Top 2% Most Influential Scientists (Single Year) in 2023 Stanford University List: Analysis of Indian Researchers". Insights2Techinfo. 2022-10-24. Retrieved 2022-12-13.
  17. ^ PR, ANI (2022-11-23). "Value of simulation-based training for cataract surgery highlighted in new articles in Indian Journal of Ophthalmology". ThePrint. Retrieved 2022-12-13.
  18. ^ Nair, Akshay Gopinathan; Narayanan, Natasha; Ali, Mohammad Javed (2020-12-31). "A Survey on the Impact of COVID-19 on Lacrimal Surgery: The Asia-Pacific Perspective". Clinical Ophthalmology. 14: 3789–3799. doi:10.2147/OPTH.S279728. ISSN 1177-5467. PMC 7649246. PMID 33177805.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  19. ^ "Asia Pacific Society Of Ophthalmic Plastic & Reconstructive Surgery | Officers". apsoprs.org. Retrieved 2022-12-13.
  20. ^ "Raman Mittal Award – OPAI". Retrieved 2022-12-13.
  21. ^ "Gangadhara Sundar Award – OPAI". Retrieved 2022-12-13.
  22. ^ "News, Tips, Resources". American Academy of Ophthalmology. 2019-08-01. Retrieved 2022-12-13.
  23. ^ "Awardees (Year 2019 & before) | APAO". Retrieved 2022-12-13.
  24. ^ Nair, Akshay Gopinathan; Goel, Shubhra; Burkat, Cat Nguyen (2019), Cohen, Adam J.; Burkat, Cat Nguyen (eds.), "Evisceration and Enucleation", Oculofacial, Orbital, and Lacrimal Surgery: A Compendium, Cham: Springer International Publishing, pp. 651–663, doi:10.1007/978-3-030-14092-2_59, ISBN 978-3-030-14092-2, retrieved 2022-12-13
  25. ^ Nair, Akshay Gopinathan (2019), Gupta, Adit; Tahiliani, Prerana (eds.), "The Role of Photography in Oculofacial Aesthetics", Orbit and Oculoplastics : Newer Trends, Singapore: Springer, pp. 1–9, doi:10.1007/978-981-13-8538-4_1, ISBN 978-981-13-8538-4, retrieved 2022-12-13
  26. ^ Gandhi, Uppal; Chhablani, Preeti Patil; Nair, Akshay G.; Chhablani, Jay (2018), Chhablani, Jay; Majumder, Parthopratim Dutta; Arevalo, J. Fernando (eds.), "Neurological Diseases", Retinal and Choroidal Imaging in Systemic Diseases, Singapore: Springer, pp. 1–14, doi:10.1007/978-981-10-5461-7_1, ISBN 978-981-10-5461-7, retrieved 2022-12-13
  27. ^ Nair, Akshay Gopinathan; Fell, David; Raouf, Sherief; Kaliki, Swathi (2018), Chhablani, Jay; Majumder, Parthopratim Dutta; Arevalo, J. Fernando (eds.), "Imaging of Retinal and Choroidal Metastases", Retinal and Choroidal Imaging in Systemic Diseases, Singapore: Springer, pp. 153–161, doi:10.1007/978-981-10-5461-7_10, ISBN 978-981-10-5461-7, retrieved 2022-12-13
  28. ^ Nair, Akshay Gopinathan; Naik, Milind N. (2017), Mukherjee, Bipasha; Yuen, Hunter (eds.), "Life-Threatening Infections", Emergencies of the Orbit and Adnexa, New Delhi: Springer India, pp. 303–313, doi:10.1007/978-81-322-1807-4_35, ISBN 978-81-322-1807-4, retrieved 2022-12-13
  29. ^ Alam, Md. Shahid; Nair, Akshay Gopinathan; Mukherjee, Bipasha (2017), Mukherjee, Bipasha; Yuen, Hunter (eds.), "Sebaceous Gland Carcinoma", Emergencies of the Orbit and Adnexa, New Delhi: Springer India, pp. 407–413, doi:10.1007/978-81-322-1807-4_45, ISBN 978-81-322-1807-4, retrieved 2022-12-13
  30. ^ Nair, Akshay Gopinathan; Mukherjee, Bipasha (2017), Mukherjee, Bipasha; Yuen, Hunter (eds.), "Periocular and Adnexal Injuries Due to Animal Bites", Emergencies of the Orbit and Adnexa, New Delhi: Springer India, pp. 33–37, doi:10.1007/978-81-322-1807-4_6, ISBN 978-81-322-1807-4, retrieved 2022-12-13